ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $1.63M invested in Entero Therapeutics in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$157K

Top Sellers

1
-$640K
2
-$51K
3
-$29K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$17K
5
Renaissance Technologies
Renaissance Technologies
New York
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$726K
2
$328K
3
$314K
4
$72K
5
$64K
6
$47K
7
$26K
8
$24K
9
$21K
10
$8K
11
–
12
–
13
–
14
–
15
–
16
–
17
–